title: Malignancy under immunosuppressive therapy including cyclosporine.
authors.affiliation: Department of Nephrology, Heinrich-Heine-University, Düsseldorf, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Ritters
authors.forename: B
authors.initials: B
authors.lastname: Grabensee
authors.forename: P
authors.initials: P
authors.lastname: Heering
mesh_terms: D000328:Adult; D001379:Azathioprine / Q000009:adverse effects; D016572:Cyclosporine / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D008775:Methylprednisolone / Q000009:adverse effects; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology*; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone